IceCure Medical (ICCM) EBITDA Margin (2020 - 2026)
IceCure Medical (ICCM) posted quarterly EBITDA Margin of 466.19% for Q1 2026, down 3822.0% year-over-year from 12.53% in Q1 2025, and up 41.43% quarter-over-quarter from 329.63% in Q4 2025.
IceCure Medical (ICCM) EBITDA Margin (2020 - 2026) Analysis & Trends
IceCure Medical (ICCM) has reported EBITDA Margin for 7 consecutive years, with 466.19% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin fell 3822.0% year-over-year to 466.19%; the TTM figure through Mar 2026 stood at 439.94% (down 3983.0% YoY), while the FY2025 annual figure was 446.7%, down 3024.0% from the prior year.
- EBITDA Margin improved to 466.19% in Q1 2026 per ICCM's latest filing, from 329.63% in the prior quarter.
- Across five years, EBITDA Margin topped out at 1260.86% in Q3 2023 and bottomed at 3146.54% in Q4 2022.
- Historically, EBITDA Margin has averaged 180.49% across 5 years, with a median of 504.41% in 2025.
- Annual changes were most pronounced in 2022 — EBITDA Margin plunged 196735 bps — and 2024, when it surged 272726 bps.
- IceCure Medical's EBITDA Margin stood at 3146.54% in 2022, then advanced by 30 bps to 2210.12% in 2023, then surged by 123 bps to 517.14% in 2024, then tumbled by 36 bps to 329.63% in 2025, then surged by 41 bps to 466.19% in 2026.
- Business Quant data shows ICCM's EBITDA Margin at 466.19% in Q1 2026, 329.63% in Q4 2025, and 451.29% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 19.15% |
| 10 | IceCure Medical | 6.79 Mn | -5.25 Mn | 253,000.00 | -1,424.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,424.26% |
| Mar 31, 2026 | 466.19% |
| Dec 31, 2025 | 329.63% |
| Sep 30, 2025 | 451.29% |
| Jun 30, 2025 | 644.76% |
| Mar 31, 2025 | 504.41% |
| Dec 31, 2024 | 517.14% |
| Sep 30, 2024 | 648.49% |
| Jun 30, 2024 | 319.29% |
| Mar 31, 2024 | 491.25% |
| Dec 31, 2023 | -2,210.12% |
| Sep 30, 2023 | 1,260.86% |
| Jun 30, 2023 | 435.54% |
| Mar 31, 2023 | 557.32% |
| Dec 31, 2022 | -3,146.54% |
| Sep 30, 2022 | 646.85% |
| Jun 30, 2022 | 559.61% |
| Mar 31, 2022 | 592.37% |
| Dec 31, 2021 | -1,179.19% |
| Sep 30, 2021 | 418.50% |